The novel therapy of the medication represents a significant advance in the management of the condition. Different to existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide322174.blogdigy.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-68079641